Streetbeat News

Stock Prices

LEVI

Telsey Advisory Group analyst Dana Telsey has maintained an Outperform rating on Levi Strauss (NYSE:LEVI) and increased the price target from $16 to $18.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 10:11 am

VLO

Raymond James analyst Justin Jenkins has reaffirmed a Strong Buy rating on Valero Energy (NYSE:VLO) and increased the price target from $154 to $155.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 10:09 am

BTC

DOGE

SOL

WIF

Cryptocurrency analyst Bluntz predicts that Dogwifhat (CRYPTO: WIF), a Solana-based meme token and Dogecoin rival, will surge beyond $1. WIF has already experienced a 5,535% increase in value after being listed on exchanges like Binance and KuCoin. Bluntz's analysis, based on the Elliott Wave theory, suggests WIF is in the second phase of a five-phase surge. Messari CEO Ryan Selkis and BitMEX co-founder Arthur Hayes have shown interest in WIF. Meanwhile, Bitcoin (CRYPTO: BTC) saw a slight decrease in price.

Portfolio Pulse from Mehab Qureshi

January 26, 2024 | 10:00 am

TSLA

Tesla, Inc. (NASDAQ:TSLA) shares dropped significantly after Q4 results missed expectations and the company forecasted lower volume growth for 2024. Elon Musk's net worth fell by $18 billion to $198 billion, but he remains the world's richest person. Musk's wealth is largely tied to his Tesla stake, and he seeks greater control in the company. Jeff Bezos, second on the billionaires' list, may see a change in net worth after Amazon's upcoming earnings report. Tesla's stock may face short to medium term pressure.

Portfolio Pulse from Shanthi Rexaline

January 26, 2024 | 9:49 am

BLK

MSCI

Jim Cramer, on CNBC's 'Mad Money,' recommended buying BlackRock Inc. (NYSE:BLK) shares, praising the company's recent quarter and its acquisition of MSCI Inc. (NYSE:MSCI). Despite warnings about geopolitical volatility affecting global markets, Cramer's endorsement comes after BlackRock's strategic move to acquire MSCI for $26 billion, which could bolster its position in the investment industry.

Portfolio Pulse from Benzinga Neuro

January 26, 2024 | 9:44 am

AXP

BAH

CL

INTC

WDC

U.S. stock futures are trading lower, with focus on earnings reports from American Express (AXP), Intel (INTC), Colgate-Palmolive (CL), Western Digital (WDC), and Booz Allen Hamilton (BAH). AXP is expected to report earnings of $2.64 per share on revenue of $16.00 billion. INTC reported higher Q4 results but forecasted a weak Q1, causing a 10.9% drop in after-hours trading. CL is expected to report earnings of 85 cents per share on revenue of $4.90 billion. WDC reported better-than-expected Q2 results but expects Q3 revenue between $3.20 billion and $3.40 billion, with potential losses, leading to a 5% drop in after-hours trading. BAH is expected to post earnings of $1.14 per share on revenue of $2.54 billion.

Portfolio Pulse from Avi Kapoor

January 26, 2024 | 9:18 am

NSC

Norfolk Southern Corporation (NYSE:NSC) is anticipated to release its Q4 earnings on Jan. 26, 2024, with expected earnings of $2.87 per share, down from $3.42 per share a year ago, and projected revenue of $3.08 billion, down from $3.24 billion. The company's Q3 FY23 results showed a revenue decline of 11% YOY to $2.97 billion, with an adjusted EPS of $2.65. NSC shares closed up 0.3% at $237.85. Analysts from JP Morgan, B of A Securities, BMO Capital, Citigroup, and Wells Fargo have recently adjusted their price targets for NSC.

Portfolio Pulse from Avi Kapoor

January 26, 2024 | 8:45 am

AXP

American Express Company (NYSE:AXP) is anticipated to report higher earnings for Q4 before the market opens on Jan. 26, 2024. Analysts predict earnings of $2.64 per share, up from $2.07 the previous year, and revenue of $16 billion, up from $14.18 billion. In Q3, AXP exceeded expectations with revenue of $15.38 billion and EPS of $3.30. AXP shares rose 1.2% to $188.07 recently. Analysts have revised their ratings and price targets, with varied opinions from Baird, JP Morgan, Citigroup, Piper Sandler, and RBC Capital.

Portfolio Pulse from Avi Kapoor

January 26, 2024 | 7:38 am

AVBP

ArriVent BioPharma has priced its upsized IPO of 9,722,222 common shares at $18 each, expecting gross proceeds of approximately $175 million. The shares will begin trading on the Nasdaq Global Market under the ticker 'AVBP' on January 26, 2024, with the offering expected to close by January 30, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 7:18 am

SGMT

Sagimet Biosciences has priced its public offering of 9 million shares of Series A common stock at $12.50 per share.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 7:08 am